Arc 15Severing Love Spirit
Three Purities developed and launched Severing Love Spirit, bringing new hope to people with HIV and prompting plans for free treatment in China. After overseas approval, high prices and rival companies’ discounts complicated the drug’s early sales.
- Tang Yamei recovered from spaceflight-related bone loss with Three Purities’ medicine, and Academician Xie invited the company to apply for future space-station life-science and aerospace-medicine research.
- Three Purities advanced clinical trials for osteoporosis and fertility treatments, while Wei Kang reviewed the company’s fourth-year revenue and set higher growth goals.
- Wei Kang approved the name Severing Love Spirit for Wenren Long’s HIV drug and promised the research team profit-sharing as the medicine moved toward clinical trials.
- Sun Chengren and his family joined Three Purities’ Helicobacter pylori trial, and Sanqing’s new antibiotic cleared their infections after the control treatment failed to cure Sun Chengren.
- Three Purities launched its portable medical monitor, whose alerts and records helped hospital staff respond to emergencies and led hospitals to place large orders.
- After trial results showed HIV levels falling with few mild side effects, Wei Kang approved Phase III trials, and Director Han agreed to work with him on a plan to provide treatment through the CDC.
- Ding Xiaomei’s tests showed no detectable HIV after her first course of treatment, and Director Han launched the HIV Eradication Plan with registration, free medication, and continued monitoring.
- Severing Love Spirit won approval in overseas markets, but GSK and Gilead cut prices and expanded assistance programs, weakening its sales as patients weighed its benefits against cost and convenience.